{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:24:45Z","timestamp":1794003885064,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboud Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejca.2026.117060","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:21:23Z","timestamp":1789831283000},"page":"117060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-1359","authenticated-orcid":false,"given":"Iris S.H.","family":"Kloots","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-763X","authenticated-orcid":false,"given":"C. Marleen","family":"Kets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-2226","authenticated-orcid":false,"given":"Janneke","family":"Schuurs-Hoeijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-1742","authenticated-orcid":false,"given":"Leonie I.","family":"Kroeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-8698","authenticated-orcid":false,"given":"Stephanie","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-1869","authenticated-orcid":false,"given":"Inge M.","family":"van Oort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiko J.","family":"Bloemendal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winald R.","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1290-1474","authenticated-orcid":false,"given":"Marjolijn J.L.","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-1831","authenticated-orcid":false,"given":"Niven","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.117060_bib1","article-title":"Clinical germline testing results of men with prostate cancer: patient-level factors and implications of NCCN guideline expansion","volume":"5","author":"Greenberg","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.117060_bib3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2026.117060_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41391-022-00609-3","article-title":"Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine","volume":"26","author":"Marino","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ejca.2026.117060_bib5","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/cancers15092435","article-title":"Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis","volume":"15","author":"Valsecchi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.117060_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib7","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-18-4070","article-title":"FDA approval summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors","volume":"25","author":"Marcus","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.117060_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.09.004","article-title":"Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial","author":"van Wilpe","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.2012.44.1238","article-title":"Elevated risk of prostate cancer among men with Lynch syndrome","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines\u00ae insights: Prostate Cancer, version 3","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2026.117060_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","article-title":"Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations","volume":"34","author":"Kuzbari","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.annonc.2026.01.015","article-title":"Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"37","author":"Fizazi","year":"2026","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib14","series-title":"Guidel Prostate Cancer","article-title":"Patient Advocate (European Prostate Cancer Coalition\/Europa UOMO)","author":"Cornford","year":"2024"},{"key":"10.1016\/j.ejca.2026.117060_bib15","unstructured":"VKGN-StOET. 14. Prostaatcarcinoom. https:\/\/vkgn.stoet.nl\/index.php?article_id=16 (2023)."},{"key":"10.1016\/j.ejca.2026.117060_bib16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/bju.16916","article-title":"Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer","volume":"136","author":"Vlaming","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.ejca.2026.117060_bib17","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","article-title":"Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer","volume":"31","author":"Castro","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41698-024-00741-4","article-title":"Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing","volume":"8","author":"Pal","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2022.08.028","article-title":"Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer","volume":"83","author":"Truong","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.117060_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JOP.19.00201","article-title":"When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?","volume":"15","author":"DeLeonardis","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ejca.2026.117060_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100518","article-title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer","volume":"7","author":"Kanesvaran","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2026.117060_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100526","article-title":"Discrepancies between tumor genomic profiling and germline genetic testing","volume":"7","author":"Pauley","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2026.117060_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190264","article-title":"Detecting likely germline variants during tumor-based molecular profiling","volume":"135","author":"Jaber","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2026.117060_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19452","article-title":"Yield and utility of germline testing following tumor sequencing in patients with cancer","volume":"3","author":"Lincoln","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2026.117060_bib26","first-page":"1","article-title":"Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study","author":"Kloots","year":"2025","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.117060_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41416-021-01663-9","article-title":"Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer","volume":"126","author":"Slootbeek","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.117060_bib28","unstructured":"Leidraad voor verwijzing na DNA-onderzoek in (tumor)weefsel. https:\/\/artsengenetica.nl\/info\/leidraad-voor-verwijzing-na-dna-onderzoek-tumorweefsel."},{"key":"10.1016\/j.ejca.2026.117060_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1373\/clinchem.2016.263897","article-title":"BRCA testing by single-molecule molecular inversion probes","volume":"63","author":"Neveling","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejca.2026.117060_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2026.117060_bib31","volume":"2025","year":"2024","journal-title":"Sticht KGCN Passant zorgproducten per 1 Jan"},{"key":"10.1016\/j.ejca.2026.117060_bib32","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/annonc\/mdz136","article-title":"Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group","volume":"30","author":"Mandelker","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib33","article-title":"Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making","volume":"2017","author":"Abida","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib34","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/1878-0261.70136","article-title":"Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18-gene panel","volume":"20","author":"Spenard","year":"2026","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.annonc.2025.04.012","article-title":"Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations","volume":"36","author":"Turnbull","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.117060_bib36","article-title":"Germline findings from tumor-only comprehensive genomic profiling in the RATIONAL study: A missed opportunity?","volume":"9","author":"Esposito Abate","year":"2025","journal-title":"JCO Precis Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926008427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926008427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:32:50Z","timestamp":1794000770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926008427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0959804926008427"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117060","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour-first DNA testing as a gateway to germline screening in patients with metastatic prostate cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117060"}}